Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels

por Dobi, Anthony, Dubernet, Arthur, Rakoto, Mahary Lalarizo, Seteyen, Anne-Laure Sandenon, Vagner, Damien, Lebeau, Grégorie, Raffray, Loïc, Gasque, Philippe
Publicado 2022